Ending the Ebola Virus Scourge A Case for Natural Products
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2016, Vol 1, Issue 1
Abstract
We investigated the binding affinities of antiviral of ethno medicinal origin to five Ebola viral proteins by in silico molecular docking simulations. One hundred and seventy three compounds were obtained from literature, extracted from ZINCĀ® database as mol2 files and further prepared for docking simulations using Auto Dock tools v. 1.5.6. Five Ebola drug targets (VP24, VP30, VP35, VP40 and NP) were obtained as pdb files from the Protein Data Bank and further prepared for docking simulations using both Chimera v. 1.8.1 and Auto Dock tools v. 1.5.6. Virtual screening and docking simulation experiments were performed using AutoDockVina 4.0 on a Linux platform. Docking results were analyzed using PyMol v.0.99r c6. At least five compounds (robustaflavone, cepharanthine, corilagin, hypericin and theaflavin) were identified as frontrunner antivirals with concurrent binding affinities on the five tested Ebola viral proteins. Binding free energies ranging between -6.225 to -8.675kcal/mol were obtained for the compounds. Compounds are recommended as experimental antivirals of ethno medicinal origin with possible anti-Ebola activities. In vitro and clinical trial investigations into the anti-Ebola activities of these compounds are recommended.
Authors and Affiliations
Uzochukwu IC*, Olubiyi OO, Ezebuo FC, Obinwa IC, Ajaegbu EE, Eze PM, Orji CE, Onuoha MC, Ejiofor II and Ikegbunam MN
A Comparative Study of Soap and Syndet Bars: Formulation, Benefits and Efficacy in Skin Care
This review presents a comprehensive comparative analysis of soap and syndet bars in the context of their formulation, benefits, and efficacy in skin care. The study examines the underlying compositions, manufacturing p...
The Evolving Definition of Comparative Effectiveness Research: Lessons for Researchers Planning and Designing a Clinical Development Program
Among the many challenges that must be overcome in successfully developing a novel drug treatment is to understand and prepare evidence that will ultimately be required by regulators and reimbursement authorities. Payers...
Therapeutic Values of Ganoderma Oregonense and Ganoderma Pfeifferi, Mushrooms: A Review
Spreading of new diseases as well as the weakness of some currently used drugs have directed scientists towards screening for new sources of biologically active compounds. Mushrooms are macrofungi that are famous for be...
In-silico Study for African Plants with Possible Beta-Cell Regeneration Effect through Inhibition of DYRK1A
Background: The continuous destruction of normal insulin-producing pancreatic beta cells is a contributing factor in all common forms of diabetes, due to insufficient production of insulin, especially in type 1 diabetes...
Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol)
Objective: FAC (5 fluorouracil, Adriamycin and cyclophosphamide) and AC (Adriamycin and cyclophosphamide) protocols have significant anti-tumor activity in patients with breast cancer. Our objective was to evaluate the C...